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Purpose:  The present study was performed to clarify the relationship between periodontal disease severity and selected im-
munological parameters consisting of serum IgG titer against periodontopathogenic bacteria, the expression of the helper T-
cell cytokine by gingival mononuclear cells, and patients’ immunoreactivity to cross-reactive heat shock protein (HSP) epitope 
peptide from P. gingivalis HSP60.
Methods:  Twenty-five patients with moderate periodontitis had their gingival connective tissue harvested of gingival mono-
nuclear cells during an open flap debridement procedure and peripheral blood was drawn by venipuncture to collect serum. 
The mean level of interproximal alveolar bone was calculated to be used as an index for periodontal disease severity for a giv-
en patient. Each of selected immunologic parameters was subject to statistical management to seek their correlations with 
the severity of periodontal disease. 
Results:  A significant correlation could not be identified between serum IgG titers against specific bacteria (Porphyromonas 
gingivalis, Prevotella intermedia, Fusobacterium nucleatum, Actinobacillus actinomycetemcomitans, and Streptococcus mutans) and 
the severity of periodontal disease. Expression of interleukin (IL)-10 by gingival mononuclear cells was statistically significant 
in the group of patients who had higher levels of alveolar bone height. However, a similar correlation could not be demon-
strated in cases for IL-4 or interferon-γ. Patients’ serum reactivity to cross-reactive epitope peptide showed a significant corre-
lation with the amount of alveolar bone.
Conclusions:  It was concluded that expression of IL-10 by gingival mononuclear cells and patients’ sero-reactivity to the 
cross-reactive HSP peptide of P. gingivalis HSP60 were significantly correlated with alveolar bone height.
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INTRODUCTION
Periodontal disease, initiated and perpetuated by concerted 
interaction between host inflammatory and immunological 
responses to the specific infecting periodontopathogenic 
bacteria, is characterized by destruction and exacerbation of 
gingival connective tissue and alveolar bone leading to even-
tual loss of teeth [1,2]. 
Earlier studies have focused on the infectious nature of dis-
ease caused by polymicrobial infection, while other studies 
have reported the relevance of disease severity to the serum 
antibody titer to an array of specific bacteria [3-5]. Most of the 
bacteria that cause the periodontal disease are gram-negative 
anaerobic or aerobic bacteria including Porphyromonas gingi-
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valis, Actinobacillus actinomycetemcomitans, Prevotella interme-
dia, and Fusobacterium nucleatum [5,6]. Naito et al. [4] reported 
that the serum antibody titer against P. gingivalis was signifi-
cantly higher in patients with periodontal disease than in 
healthy controls, and found that the high antibody titer was 
remarkably reduced after periodontal treatment [7]. Kojima 
et al. [8] also reported a close positive correlation between the 
serum antibody titer against P. gingivalis and periodontal dis-
ease status. According to the longitudinal study performed 
by Taubman et al. [9], the serum antibody to a specific oral 
bacterium remained comparatively stable; however, the titer 
reflected the disease activity, i.e. active or quiescent. It ap-
pears that the antibody response to bacteria may play a criti-
cal role in the host defense system, but there have not been 
any clear explanations with regard to the functional role of 
the serum antibody.
The latest concept based in osteoimmunology claims that 
the activated T-cell is the primary source of the receptor acti-
vator for nuclear factor kappa B ligand (RANKL), which is 
necessary for the differentiation and activation of osteoclasts 
stimulating alveolar bone destruction. Based on a variety of 
studies carried out on the bacterial antigen-specific CD4-
positive T-cell secreting characteristic cytokine profiles, the 
type 1 helper T-cell is reported to be closely related to the ex-
pression of RANKL-mediated alveolar bone destruction [10,11]. 
In contrast, a type 2 helper T-cell cytokine, interleukin (IL)-10, 
is known to inhibit bone resorption as reported by Liu et al. 
[12], who observed that IL-10 promotes the expression of os-
teoprotegerin and inhibits the expression of colony stimulat-
ing factor-1 and RANKL. This hypothesis is supported by the 
observation that alveolar bone destruction was pronounced 
in IL-10 knockout mice in experimentally-induced periodon-
titis [13-15]. Takayanagi et al. [16] reported that the type 1 help-
er T-cell cytokine, interferon gamma (IFN-γ), disturbs the 
RANKL-RANK signaling system and inhibits alveolar bone 
destruction. However, it turned out to promote the expres-
sion of RANKL, thus increasing the alveolar bone destruction 
[17-19]. 
As the autoimmune characteristics of periodontal disease 
have recently been demonstrated, heat shock protein (HSP), 
a principal antigen that stimulates the host immunological 
response, has attracted scientific interest. It is generated 
when cells are exposed to various stimuli and is well con-
served through evolution maintaining high degree of se-
quence homology between mammalian and bacterial HSPs 
[20,21]. Choi et al. [22,23] and Chung et al. [24] have demon-
strated the immunologic cross-reactivity of HSP in the con-
text of provoking autoimmune diseases such as arterioscle-
rosis and rheumatoid arthritis. Ueki et al. [25] found the 
cross-reaction between periodontal pathogenic bacteria and 
human HSP, which stimulated the expression of pro-inflam-
matory cytokine and induced chronic tissue destruction 
from the periodontal lesion. Nevertheless, most recent stud-
ies claim that T-cells specific to human HSP manifest the 
immunoregulatory phenotype characteristic of CD4, CD25, 
and FoxP3 phenotypes, and functions to inhibit autoimmune 
responses [26,27]. The stimulus to bacterial HSP60-specific 
epitope, which cross-reacts with human HSP60, activated the 
regulatory T-cell in experiments with arthritic Lewis rats [28-
30]. Lee et al. [31] have recently identified a peptide epitope 
(TLVVNRLRGSLKICAVKAPG) of P. gingivalis HSP60 that 
shows cross-reactivity with its human counterpart with the 
prospect of defining immunoregulatory function of the 
epitope. While several studies have been carried out as to 
what relationship bacterial HSP60 has to arteriosclerosis or 
rheumatic arthritis, there have been few studies on the exact 
role of bacterial HSP60 in the etiology of periodontal dis-
ease. 
The question arises as to what kinds of immunologic pa-
rameters, either alone or in combination, are closely associ-
ated with periodontal disease severity. Hence, the present 
study was performed to clarify the relationship between peri-
odontal disease severity and an array of immunological pa-
rameters consisting of the expression of the helper T-cell cy-
tokine, the serologic reactivity to cross-reactive HSP peptide, 
and serum immunoglobulin G (IgG) titer against periodontal 
pathogenic bacteria.
MATERIALS AND METHODS
Study subjects
Twenty-five patients (12 males and 13 females, 39-63 years 
of age), who were diagnosed as having moderate chronic 
periodontitis at the Department of Periodontics Clinic, Pusan 
National University Hospital, participated in the study. They 
had no history of systemic diseases contributing to peri-
odontal disease. Prior to treatment, a 5-mL sample of blood 
was collected by venipuncture. Gingival connective tissue 
samples were harvested via open flap debridement to collect 
gingival mononuclear cells. The level of alveolar bone was 
evaluated on the basis of alveolar bone height, being calcu-
lated as a proportion (%) of the relative distance between the 
alveolar crest and root apex to the total length of the root mea-
sured on the radiographic image. For defining the periodontal 
disease severity, patients were classified into two groups; one 
group (Group A) consisted of those whose alveolar bone 
heights were greater than 70%, while the other group (Group 
B) consisted of those with bone heights under 70%. This 
study was approved by the Pusan National University Dental 
Hospital Institutional Review Board (2008019). Journal of Periodontal
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Measurement of serum IgG titer to periodontopathogenic 
bacteria
Serum IgG titer to periodontopathogenic bacteria were de-
termined by enzyme-linked immunosorbent assay (ELISA). 
Briefly, microtiter plates were coated respectively with bacte-
ria (P. ginivalis, A. actinomycetemcomitans, P. intermedia, F. nu-
cleatum, Streptococcus mutans) and diluted (10 μg/mL) in phos-
phate buffer [2]. The plates were washed and an aliquot of se-
rum samples serially diluted was added and incubated. The 
plates were washed, and peroxidase-conjugated mouse anti-
human IgG (γ-chain-specific, Jackson ImmunoResearch Lab-
oratories, West Grove, USA) was added. After 2 hours of incu-
bation, the plates were washed and an aliquot of tetrameth-
ylbenzidine (Kirkegaard and Perry Laboratories, Gaithers-
burg, USA) was added for incubation followed by the addi-
tion of 0.18 M H2SO4 to stop the reaction. Optical densities 
read at 450 nm were plotted as a function of the serum dilu-
tion factor. The serum dilution factor corresponding to an 
optical density of 0.5 was designated as antibody titer.
Expression of T-cell cytokines by gingival mononuclear 
cells
Total RNA was isolated from gingival tissues using the Tri-
zol method and dried until solubilization for reverase tran-
scriptase-polymerase chain reaction (RT-PCR). For detection 
of gene expression, 2 μg of total RNA from each sample was 
reverse transcribed by M-MLV reverse transcriptase (Invitro-
gen, Carsbad, USA) to synthesize cDNA, in a 25 μL reaction 
volume, according to the manufacturer’s instructions. The 
reverse transcription reaction was carried out at 37°C for 1 
hour, followed by a 10-minute incubation at 70°C. Primers 
were designed based on the cDNA nucleotide sequences of 
the human IL-4 gene, IL-10 gene, IFN-γ gene, and β-actin. 
Oligonucleotide primers are as follows: IL-4, 5‘-AGAGCA-
GAAGACTCTGTGCA-3’ (sense) and 5’-CCAACGTACTCTG-
GTTGGCT-3’ (antisense); IL-10, 5’-CCAACGTACTCTGGTT-
GGCT-3’ (sense) and 5’-GCCTTTCTCTT GGAGCTTAT-3’ 
(antisense); IFN-γ, 5’-CAGGACCCATATGTAAAAGA-3’ (sense) 
and 5’-TCGCTTCCCTGTTTTAGCTG-3’ (antisense); and 
β-actin, 5’-TAAGGAGAAGCTGTGCTACG-3’ (sense) and 
5’-CCGATCCACACGGAGTACTT-3’ (antisense). Polymerase 
chain reaction was performed in a 100 μL reaction volume 
containing 10 μL of first-strand cDNA as a template, 10X PCR 
reaction buffer, 2 μL of each dNTP, 0.5 μL of each sense 
primer, 0.3 μL of each antisense primer, and 0.5 μL of ampli-
Taq DNA polymerase (Applied Biosystems, Foster City, USA). 
The reaction was carried out for 35 cycles. For each cycle, de-
naturation was carried out at 94°C for 1 minute, annealing at 
49-59°C for 1 minute, and extension at 72°C for 1 minute. The 
β-actin gene was amplified in parallel, in all PCR amplifica-
tions, as an internal control. After the PCR reaction, 10 μL of 
PCR product was loaded onto an 1.7% agarose gel and 
stained with ethidium bromide.
Dot immunoblot analysis
Peptides #19 of P. gingivalis HSP60 (TLVVNRLRGSLKI-
CAVKAPG) and human HSP60 (TLVLNRLKVGLQV-
VAVKAPG) were each spotted onto polyvinyliden fluoride 
membrane. The membrane was blocked with 5% skim milk 
followed by adding the monoclonal antibody in PBS buffer 
for incubation for 2 hours at room temperature. After wash-
ing the membrane, horseradish peroxidase-conjugated goat 
anti-mouse IgG (γ-chain specific, Jackson ImmunoResearch 
Laboratories, West Grove, USA) was added and incubated for 
1 hour. The membrane was then washed with PBS-Tween 
followed by adding tetramethylbenzidine for color develop-
ment. 
Statistical analysis
For statistical processing, SPSS ver. 14.0 (SPSS Inc., Chicago, 
USA) was used. The significance level was determined at a 
95% confidence interval. To compare the serum antibody ti-
ters of periodontal pathogenic bacteria according to alveolar 
bone levels, the independent samples t-test was applied to 
the average calculated in each group. The correlation be-
tween the expression patterns of helper T-cell cytokine, relat-
ed to alveolar bone level, and the serologic reactivity of cross-
reactive HSP peptide, was analyzed by use of Fisher’s exact 
test.
RESULTS
Patient groups
An open flap debridement procedure was performed on 25 
patients with chronic periodontitis, and gingival connective 
tissues were harvested in the process of surgery. According 
to the criteria described in the methods section, all the pa-
tients were classified into two groups, Group A and Group B, 
according to the mean alveolar bone height of the patients. 
Then, the group was subdivided into Group 1 and Group 2 
according to the mean alveolar bone height of the regions of 
interest where tissues were collected during the surgical pro-
cedure. The characteristics of each group are described in 
Table 1. Age and gender distribution of study subjects in Groups A 
and B.
Number Age (mean ± SD) Male/Female
Group A 10 57.5 ± 4.35 5/5
Group B 15 48.2 ± 5.03 7/8
Overall 25 51.9 ± 6.59 12/13Journal of Periodontal
& Implant Science JPIS
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Tables 1 and 2.
Serum IgG antibody titers to periodontopathogenic bacteria
Patients’ serum IgG titers against each type of bacteria (P. 
gingivalis, P. intermedia, F. nucleatum, S. mutans, and A. actino-
mycetemcomitans) were determined by use of ELISA to seek 
the correlation between periodontal disease severity and se-
rum IgG titer by statistical analysis. For all the bacteria tested, 
IgG antibody titers were higher in Group B than in Group A. 
However, there was no significant difference observed be-
tween the two groups (Table 3).
Expression of T-cell cytokines by gingival mononuclear 
cells
The RT-PCR patterns of helper T-cell cytokines (IL-10, IL-4, 
and IFN-γ) expressed by gingival mononuclear cells are de-
picted (Fig. 1). There were various expression patterns of cy-
tokines from gingival mononuclear cells among patients. In 
Group 1, IL-10 was expressed in 4 patients, while in the case 
of Group 2, IL-10 was expressed in 1 patient, thus demon-
strating a significant correlation between the expression of 
IL-10 and alveolar bone level (P<0.05) (Table 4). IFN-γ expres-
sion tended to be more frequently observed in Group 2 than 
in Group 1. However, significant correlation could not be ob-
served (P>0.05) (Table 5). IL-4 was expressed in 1 patient in 
Group 1, but again there was no statistical significance (P> 
0.05) (Table 6). 
Dot immunoblot analysis
The dot immunoblot patterns of serum response to P. gin-
givalis HSP60 #19 peptide and human HSP60 #19 peptide 
Table 3. Serum IgG antibody titers against tested periodontopatho-
genic bacteria (enzyme-linked immunosorbent assay unit, mean ±   
SD).
Group A Group B P-value
a)
P. gingivalis 7,729 ± 2,211 8,137 ± 1,415 0.578
P. intermedia 1,206 ± 551 1,417 ± 488 0.326
F. nucleatum 2,361 ± 3,475 2,832 ± 3,194 0.730
S. mutans 3,751 ± 2,546 3,811 ± 2,155 0.951
A. actinomycetemcomitans 878 ± 679 993 ± 438 0.610
a)Independent t-tests were used to test statistical significance between the 
groups (P<0.05).
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4  5 6  7 8 9
Group 1
IL-10
IFN-γ
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1            2           3             4          5         6           7            8         9            10          11      12          13       14         15     16    actin 
1            2        3            4           5           6            7            8            9            10      11      12          13        14        15        16    actin 
1            2           3             4          5         6           7           8         9             10         11       12         13        14        15        16    actin 
Figure 1. Expression pattern of helper T-cell cytokine (interleukin [IL]-10, interferon gamma [IFN-γ], IL-4) by gingival tissues obtained from 
25 periodontal patients.
Table 2. Mean alveolar bone height of sampled sites in groups 1 and 
2.
Number Age (mean ± SD) Male/Female
Group 1 9 53.2 ± 6.79 5/4
Group 2 16 51.2 ± 6.58 7/9
Overall 25 51.9 ± 6.59 12/13Journal of Periodontal
& Implant Science JPIS
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were evaluated (Fig. 2). Five out of 10 patients in Group A 
demonstrated serum cross-reactivity to peptide #19 of both P. 
gingivalis HSP60 and human HSP60 #19 peptide, while 1 out 
of 16 patients in Group B demonstrated serum cross-reactiv-
ity. These patterns of serum cross-reactivity to peptide #19 
were significantly correlated to alveolar bone level (P<0.05) 
(Table 7).
DISCUSSION
Periodontal disease is initiated and exacerbated by fine tun-
ing of the host inflammatory and the immunological re-
sponse to the multiple pathogenic bacteria infecting the sub-
gingival niche. However, there has not been a clear explana-
tion of the role of the serum antibody to bacteria in peri-
odontal disease, the correlation between alveolar bone de-
struction and helper T-cell cytokine, and the role of HSP in 
the etiology of periodontal disease.
It has been reported in previous studies that the serum IgG 
titer is higher in patients with chronic or aggressive peri-
odontal disease than in healthy controls [3,4,32]. However, it 
is not clear if the serum IgG titer correctly reflects disease ac-
tivity or severity. In the present study, serum antibody titers 
against 5 key periodontopathogenic bacteria (P. gingivalis, P. 
intermedia, F. nucleatum, S. mutans, and A. actinomycetemcomi-
tans) and their correlation with alveolar bone height was an-
Table 6. Correlation between alveolar bone height and expression 
of interleukin (IL)-4.
Group 1 Group 2 Sum
IL-4 expression 1 (4) 0 (0) 1 (4)
No IL-4 expression 8 (32) 16 (64) 24 (96)
Sum 9 (36) 16 (64) 25 (100)
Values are presented as number (%).
Fisher’s exact test: no statistically significant difference between Group 1 and 2 
(P<0.05).
Table 7. Correlation between alveolar bone height and pattern of 
cross-recognition of peptide #19 from P. gingivalis HSP60 and hu-
man HSP60.
Group A Group B Sum
Cross-recognition 5 (20) 1 (4) 6 (24)
No cross-recognition 5 (20) 14 (56) 19 (76)
Sum 10 (40) 15 (60) 25 (100)
Values are presented as number (%).
Fisher’s exact test: statistically significant difference (P<0.05).
HSP: heat shock protein.
Table 4. Correlation between alveolar bone height and expression 
of interleukin (IL)-10.
Group 1 Group 2 Sum
IL-10 expression 4 (16) 1 (4) 5 (20)
No IL-10 expression 5 (20) 15 (60) 20 (80)
Sum 9 (36) 16 (64) 25 (100)
Values are presented as number (%).
Fisher’s exact test: statistically significant difference between Group 1 and 2 
(P<0.05).
Table 5. Correlation between alveolar bone height and expression 
of interferon gamma (IFN-γ).
Group 1 Group 2 Sum
IFN-γ expression 4 (16) 6 (24) 10 (40)
No IFN-γ expression 5 (20) 10 (40) 15 (60)
Sum 9 (36) 16 (64) 25 (100)
Values are presented as number (%).
Fisher’s exact test: no statistically significant difference between Group 1 and 2 
(P<0.05).
Figure 2. Dot immunoblot patterns of serum to peptide #19 from P. 
gingivalis heat shock protein (HSP, pg#19) and human HSP60 
(hu#19), respectively, in Group A and B patients.
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alyzed. The serum antibody titer was higher in Group B (al-
veolar bone height was less than 70%) than in Group A (alve-
olar bone height was greater than 70%) of all the tested or-
ganisms, but significant differences could not be delineated. 
This might be because the comparison has been made with-
in patients manifesting varying degrees of alveolar bone de-
struction in the present study, while other previous studies 
have compared patient serum titers to those of the healthy 
control subjects. It might also be that our observation may 
imply that the serum antibody titer cannot accurately reflect 
the current level of alveolar bone as an indicator for peri-
odontal disease severity. Horibe et al. [33] reported that the 
serum IgG titer against P. gingivalis and P. intermedia was sig-
nificantly decreased after periodontal treatment. Taubman et 
al. [9], who performed a longitudinal study, explained that the 
serum antibody titer against bacteria changed only accord-
ing to disease activation or periodontal treatment. Anderson 
et al. [34] observed that, in other disease cases, the increase of 
the serum antibody titer may defend against pathogenic bac-
teria, but in the case of periodontal disease, it cannot func-
tion as the protector. Based on the results of previous studies, 
it appeared that the serum antibody titer against specific 
periodontopathogenic bacteria might increase in proportion 
to the severity of periodontal disease, but this phenomenon 
was not be observed in the present study. To clarify the cor-
relation between the serum antibody titer and periodontal 
disease severity, other criteria for periodontal disease severity 
may have to be adopted in future study designs. 
IFN-γ, one of the type 1 helper T-cell cytokines, promotes 
the generation of proinflammatory cytokine such as IL-1 and 
tumor necrosis factor-alpha from gingival mononuclear 
cells. On the other hand, IL-4 and IL-10, cytokines secreted 
by type 2 helper T-cells, inhibit pro-inflammatory cytokine 
and type 1 helper T-cell cytokine [10,35,36]. In recent studies 
relevant to the role of type 2 helper T-cell cytokine in infec-
tion-related inflammatory bone resorption, IL-10 is reported 
to play a principal role in inhibiting bone resorption, while 
IL-4 does not take any noticeable role [37-39]. Sasaki et al. [39], 
who compared IL-10 knockout mice with IL-4 knockout mice 
for the destructive patterns of alveolar bones in experimen-
tally-induced periodontitis, reported that alveolar bone de-
struction was remarkable in IL-10 knockout mice, but that 
there were no significant differences between IL-4 knockout 
mice and the wild-type control group. Takayanagi et al. [16] 
reported that IFN-γ disturbed the RANKL-RANK signaling 
system and rapidly degenerated the functions of RANK 
adapter protein and tumor necrosis factor receptor associat-
ed factor 6, and thus strongly inhibits the differentiation of 
osteoclasts. However, in recent experiments by humanized 
nonobese diabetic/severe combined immunodeficiency (NOD/ 
SCID) and diabetic NOD mice systems, IFN-γ stimulated the 
expression of RANKL leading to an increase in alveolar bone 
destruction [17-19]. IL-10 was significantly increased in Group 
1 (alveolar bone height was greater than 70% in the sampled 
sites) rather than in Group 2 (alveolar bone height was less 
than 70%). IL-10 expression was positively correlated with al-
veolar bone height; however, IL-4 was expressed only in 1 pa-
tient of Group 2 on the other hand. Thus there was no corre-
lation between the expression of IL-4 and the alveolar bone 
height. This finding is consistent with previous studies on 
type 1 helper T-cell cytokine, though what exact mechanism 
of IL-4 has not been delineated in the process of alveolar 
bone destruction. It appears that IL-10 plays a crucial role in 
modulating the homeostasis of bone metabolism. IFN-γ 
tended to be expressed more frequently in Group 2 than in 
Group 1, but a statistically significant correlation could not be 
observed. This result was not consistent with the results of 
Teng et al. [17], who reported that alveolar bone destruction 
and IFN-γ expression showed a positive correlation in peri-
odontal disease. This might be because of a difference in the 
design of the experimental group: with moderate periodon-
titis patients in our study and aggressive periodontitis pa-
tients in the Teng group [17]. There has not been a clear ex-
planation as to what osteoclast-related RANKL expression 
has to do with IFN-γ. The exact role of IFN-γ in the progres-
sion of periodontal disease has to be clarified further.
As the autoimmune characteristics of periodontal disease 
have been recently reported, HSP comprises a principal anti-
gen that stimulates the host immunological response. HSP is 
very well-conserved in sequence, sharing a high degree of 
sequence homology between bacterial species and all living 
organisms [20,21]. In particular, HSP60 functions as a princi-
pal antigen in various infectious diseases [40]. Early studies 
on HSP were focused on autoimmune disease caused by im-
munologic cross-reactivity between bacterial HSP and its 
human counterpart [24,25]. However, most recently, T-cells 
responding to cross-reactive epitope of human HSP express 
the immunoregulatory phenotypes and functions that inhib-
it the autoimmune responses in the inflammatory disease 
process [26,27]. Through an experiment in which arthritic 
Lewis rats were used, the cross-reactive epitope of bacterial 
HSP60 and human HSP60 exert an important role in the im-
munoregulatory mechanism of HSP60 [28-30]. Many studies 
have been carried out with regard to the immunoregulatory 
mechanism of HSP60 in autoimmune disease including 
rheumatoid arthritis, atherosclerosis, and diabetes, but there 
have been only a few studies on the immunoregulatory 
mechanism of periodontal disease. Recently, Choi et al. [31] 
have produced a poly-reactive monoclonal antibody to P. 
gingivalis HSP60, which recognized tan immunodominant Journal of Periodontal
& Implant Science JPIS
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epitope (peptide #19) of P. gingivalis HSP60, that cross-react-
ed with peptide #19 from human HSP60. Thus, we have ana-
lyzed patients’ sera for cross-reactivity to peptide #19 from 
both P. gingivalis HSP60 and human HSP60 in Group A and 
B patients. The sero-reactivity to cross-reactive HSP peptide 
was more frequent in Group A when compared to Group B. 
The reactivity of serum to peptide #19 from both P. gingivalis 
HSP60 and its human counterpart demonstrated a statisti-
cally significant positive correlation to alveolar bone height. 
This result was consistent with those of previous findings in 
an autoimmune arthritis study. It supports the latest hypoth-
esis that the stimulus of specific cross-reactive epitope (pep-
tide #19 of P. gingivalis HSP60) stimulates the development 
of regulatory T-cells (expressing CD4+, CD25+, FoxP3+ phe-
notypes) inducing immune tolerance, and inhibits the alveo-
lar bone destruction. Even though the immunoregulatory 
mechanism of HSP60 in periodontal disease has not been 
clarified in detail, it is presumable that T-cells responsive to 
the cross-reactive epitope peptide may play a pivotal role in 
regulating the immune responses in the development or 
prevention of periodontal diseases.
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